Date published: 2025-9-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

GalNAc-T5 Inhibitors

GalNAc-T5 inhibitors are a specialized class of chemical compounds that interact with the enzyme N-acetylgalactosaminyltransferase 5 (GalNAc-T5). This enzyme is a member of the GalNAc transferase family, which plays a crucial role in the O-glycosylation process, where a GalNAc (N-acetylgalactosamine) moiety is transferred to serine or threonine residues on target proteins. The O-glycosylation process is fundamental in the post-translational modification of proteins, influencing their structure, stability, and function. GalNAc-T5, in particular, is one of several isoforms within this family, each with distinct substrate specificities and tissue distributions. Inhibitors of GalNAc-T5 typically function by binding to the active site of the enzyme or its allosteric sites, preventing the transfer of GalNAc to the target protein. This inhibition can lead to changes in the glycosylation pattern of proteins, which in turn can alter their biological activity, interactions, and stability. Chemically, GalNAc-T5 inhibitors may vary significantly in structure, ranging from small molecules to more complex scaffolds. The design of these inhibitors often involves detailed knowledge of the enzyme's three-dimensional structure, particularly the configuration of its active site. Computational modeling and structure-activity relationship (SAR) studies are commonly employed to optimize inhibitor binding affinity and selectivity. Some inhibitors are designed to mimic the natural substrates or transition states of the glycosylation reaction, thus competing effectively with the enzyme's natural activity. Additionally, the specificity of these inhibitors for GalNAc-T5 over other members of the GalNAc transferase family is a key area of research, as it is important to precisely modulate the activity of GalNAc-T5 without affecting other related enzymes. The development and study of GalNAc-T5 inhibitors provide valuable insights into the broader mechanisms of protein glycosylation and its regulation within cellular systems, contributing to our understanding of protein function and the complex biochemical networks that govern cellular processes.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A may cause hyperacetylation of histones around the GalNAc-T5 gene, potentially leading to tight chromatin packing that silences the gene's transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound could induce DNA demethylation at the promoter region of the GalNAc-T5 gene, resulting in the downregulation of its mRNA and protein levels.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG 108 might block the methylation of CpG islands near the GalNAc-T5 locus, promoting a state less conducive to gene transcription and thus reducing enzyme levels.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

By intercalating DNA, Actinomycin D directly inhibits RNA polymerase movement, which would decrease the transcription rate of the GalNAc-T5 gene.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin specifically targets RNA polymerase II, which transcribes mRNA, thereby reducing the synthesis of GalNAc-T5 mRNA transcripts.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide inhibits the elongation phase of mRNA translation on ribosomes, which would result in a decrease in GalNAc-T5 protein production.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin suppresses mTORC1 signaling, which could downregulate the translation of proteins including GalNAc-T5 by inhibiting cap-dependent initiation.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2′-Deoxycytidine incorporation into DNA could lead to the hypomethylation of the GalNAc-T5 gene, potentially resulting in sustained downregulation of gene expression.

Sinefungin

58944-73-3sc-203263
sc-203263B
sc-203263C
sc-203263A
1 mg
100 mg
1 g
10 mg
$266.00
$5100.00
$39576.00
$690.00
4
(1)

As a universal methyltransferase inhibitor, Sinefungin may prevent methylation of the GalNAc-T5 promoter, thereby reducing its transcriptional activity.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol binds to and inhibits CDKs, which may lead to reduced phosphorylation of transcription factors necessary for GalNAc-T5 transcription.